The biotech news you missed this week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Medicine
STAT+: Pharmalittle: We’re reading about AbbVie spending on doctors, a new Lilly deal, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Biden administration appeals jury finding in battle over patents for HIV prevention pills
The Biden administration has appealed a decision in which a federal court jury last year…
STAT+: Eli Lilly to acquire Morphic for $3.2 billion
Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for…
Opinion: EcoHealth Alliance: Covid’s anti-science mob extracting its pound of flesh
Imagine this post-9/11 scenario: A New York City fire company is forced to shut down…
STAT+: Troubled for-profit chains are stealthily operating dozens of psychiatric hospitals under nonprofits’ names
Come quickly, the Columbus Police sergeant urged, patients are in danger. The psychiatric hospital on…
Bird flu snapshot: Live H5N1 virus grown from raw milk samples as Delaware moves to legalize its sale
Bird flu snapshot: This is the latest installment in a series of regular updates on…
Opinion: The ethical implications of Elon Musk’s unorthodox approach to medical science
Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates…
Opinion: First Opinion readers respond to psychiatry and social contracts, Medicare and weight loss meds, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
GLP-1s lower risk of 10 obesity-associated cancers, study shows
New research found that the GLP-1 class of drugs — glucagon-like peptide receptor agonists —…
STAT+: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors
WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to…
STAT+: Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation
WASHINGTON — A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug…
STAT+: U.K. trade group scolds Novo, Novartis, Pfizer and Otsuka for violating industry codes
Four large drugmakers — Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical — were scolded by…
STAT+: Pharmalittle: We’re reading about Ozempic and an eye condition, a failed Roche cancer drug trial, and more
And so, another working week will soon draw to a close. Not a moment too…
Opinion: My stalled relay race to get access to ALS drugs in development
One night in November 2018, I fell while crossing a street in Subic Bay, a…
Constructing an atlas of human biology in space: Q&A with Chris Mason
After several delays, the highly anticipated first commercial spacewalk is set to launch later this…
STAT+: Top Biden administration officials withdraw from Coalition for Health AI
Top Biden administration officials have withdrawn from an industry body formed to set safety standards…
Why a blue state embraced raw milk, despite bird flu and other health risks
DOVER, Del. – The mood in the Delaware General Assembly chamber was jovial last Thursday…
STAT+: Regulating artificial intelligence doesn’t have to be complicated, some experts say
Artificial intelligence has the potential to revolutionize how drugs are discovered and change how hospitals…
STAT+: New Medicare Advantage star ratings give extra bonuses to multiple insurers
More than two dozen Medicare Advantage insurers received higher quality marks for 2024, based on…
New federal rule proposed to protect 36 million workers from extreme heat
WASHINGTON — President Joe Biden on Tuesday proposed a new rule to address excessive heat in…
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor…
Opinion: President Biden must take a cognitive screening test. Voters deserve to know the results
In the aftermath of President Biden’s debate with former President Trump last week, many of…
Study links Ozempic to higher risk of eye condition that can cause vision loss
A new observational study on Wednesday reported for the first time a potential link between…
.jpg)
After Biden debate performance, experts reflect on difference between ‘normal aging’ and something more
In the days after Thursday’s presidential debate, one of the questions that was asked on…
STAT+: Pharmalittle: We’re reading about a GSK vaccine deal, an Alzheimer’s drug approval, and more
Top of the morning to you, and a fine one it is. The skies are…
GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership
GSK and CureVac have restructured an ongoing partnership that gives the British pharma giant control…
STAT+: What’s next for Cassava Sciences, and Cartesian Therapeutics has a novel excuse for dodgy data
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
As bird flu spreads among U.S. cattle, veterinarians find themselves in a familiar position: the frontlines
When, in April, the federal government began requiring some cows to be tested for a…
Opinion: Listen: Why is eugenics still alive and well in scientific publishing?
While the bogus science of eugenics — the idea that the human race can be…
Opinion: Can the National Institutes of Health navigate multiple storms and rebuild its bipartisan support?
Few federal agencies have enjoyed a more sterling reputation on Capitol Hill over the past…
CDC looks to expand capacity to test for H5N1 bird flu in people
As the H5N1 bird flu outbreak in dairy cows enters its fourth month, the Centers…
STAT+: FDA approves Eli Lilly’s early Alzheimer’s treatment
Eli Lilly’s early Alzhiemer’s treatment was approved by the Food and Drug Administration on Tuesday,…
STAT+: Former Mass General president Peter Slavin will run Cedars-Sinai in Los Angeles
Peter Slavin, who ran Massachusetts General Hospital in Boston for nearly two decades before stepping…
STAT+: Report shows U.S. biotechs are wary of Chinese partnerships due to looming BIOSECURE Act
A looming anti-China biotechnology bill has spooked U.S. life sciences companies, according to a new…
Making sense of the debate’s health care debate
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Supreme Court to weigh whether the FDA was heavy-handed with flavored e-cigarette products
WASHINGTON — The Supreme Court took up an e-cigarette case Tuesday, weighing whether the Food…
.jpg)
STAT+: Pharmalittle: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
Moderna receives $176 million from BARDA for mRNA influenza vaccines
Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to…
STAT+: How controversial was the decision by FDA’s Peter Marks to approve Sarepta’s gene therapy? Check its footnotes
The unilateral decision by Peter Marks, a top official at the Food and Drug Administration,…
Q&A: The U.S. is losing control of hypertension. China’s ‘village doctors’ have lessons
The U.S. has slid backward on control of high blood pressure, despite ready access to…
Opinion: Senate, FTC cracking down on pharma patent shenanigans
Why do Americans pay so much more for common medications than people in other countries?…
STAT+: The biotech scorecard for the third quarter: 19 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third…
Opinion: The rare pediatric disease voucher program creates new treatments. I have new data to prove it
The Food and Drug Administration’s rare pediatric disease priority review voucher program, which has been…
STAT+: This AI chat bot was trained on drag queens, and she wants to help protect your sexual health
A few months ago, a young Black gay patient in a southern state tapped out…
Microbiome composition varies based on sampling time, mouse study finds
The microbiome has immense power to shape health outcomes. The bacteria that take up residence…
STAT+: After months of warnings, FTC opens investigation into Teva over ‘improper’ patents
The U.S. Federal Trade Commission is formally investigating Teva Pharmaceuticals after the company refused to…
STAT+: Steward Health Care spent millions on surveillance of its critics — even amid financial crisis
This story was reported by Hanna Krueger, Jessica Bartlett, Mark Arsenault, and Elizabeth Koh. It was written by Krueger…
STAT+: Novel amputation procedure makes walking with a prosthetic leg feel more seamless
A novel surgical technique could dramatically improve walking for people with below-the-knee amputations and help…
STAT+: Pharmalittle: We’re reading about indicted drug wholesalers, a gene therapy rejection, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…